151 related articles for article (PubMed ID: 17673260)
1. WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat.
Vera G; Chiarlone A; Cabezos PA; Pascual D; Martín MI; Abalo R
Life Sci; 2007 Jul; 81(6):468-79. PubMed ID: 17673260
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat.
Abalo R; Cabezos PA; Vera G; López-Pérez AE; Martín MI
Neurogastroenterol Motil; 2013 May; 25(5):373-82, e292. PubMed ID: 23594243
[TBL] [Abstract][Full Text] [Related]
3. Altered feeding behaviour induced by long-term cisplatin in rats.
Vera G; Chiarlone A; Martín MI; Abalo R
Auton Neurosci; 2006 Jun; 126-127():81-92. PubMed ID: 16567130
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica.
Cabezos PA; Vera G; Martín-Fontelles MI; Fernández-Pujol R; Abalo R
Neurogastroenterol Motil; 2010 Jul; 22(7):797-805, e224-5. PubMed ID: 20236245
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C
Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260
[TBL] [Abstract][Full Text] [Related]
6. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
Pascual D; Goicoechea C; Suardíaz M; Martín MI
Pain; 2005 Nov; 118(1-2):23-34. PubMed ID: 16213089
[TBL] [Abstract][Full Text] [Related]
7. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
Radziszewska E; Bojanowska E
Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
[TBL] [Abstract][Full Text] [Related]
8. Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat.
Abalo R; Cabezos PA; López-Miranda V; Vera G; González C; Castillo M; Fernández-Pujol R; Martín MI
Neurogastroenterol Motil; 2009 Sep; 21(9):1002-e80. PubMed ID: 19413685
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat.
De Jonghe BC; Horn CC
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R756-65. PubMed ID: 18184757
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat.
Vera G; López-Gómez L; Girón R; Martín-Fontelles MI; Nurgali K; Abalo R; Uranga JA
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833878
[TBL] [Abstract][Full Text] [Related]
11. The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.
Ulugol A; Karadag HC; Ipci Y; Tamer M; Dokmeci I
Neurosci Lett; 2004 Nov; 371(2-3):167-70. PubMed ID: 15519750
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
13. Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain.
Guindon J; Desroches J; Dani M; Beaulieu P
Eur J Pharmacol; 2007 Jul; 568(1-3):173-6. PubMed ID: 17555742
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy.
Vera G; Cabezos PA; Martín MI; Abalo R
Pharmacol Biochem Behav; 2013 Apr; 105():205-12. PubMed ID: 23454533
[TBL] [Abstract][Full Text] [Related]
15. Effect of styrene maleic acid WIN55,212-2 micelles on neuropathic pain in a rat model.
Linsell O; Brownjohn PW; Nehoff H; Greish K; Ashton JC
J Drug Target; 2015 May; 23(4):353-9. PubMed ID: 25541465
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
Burgos E; Pascual D; Martín MI; Goicoechea C
Eur J Pain; 2010 Jan; 14(1):40-8. PubMed ID: 19318283
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats.
Li J; Daughters RS; Bullis C; Bengiamin R; Stucky MW; Brennan J; Simone DA
Pain; 1999 May; 81(1-2):25-33. PubMed ID: 10353490
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes.
Vera G; López-Miranda V; Herradón E; Martín MI; Abalo R
Pharmacol Biochem Behav; 2012 Aug; 102(2):335-43. PubMed ID: 22609797
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats.
Lim G; Sung B; Ji RR; Mao J
Pain; 2003 Sep; 105(1-2):275-83. PubMed ID: 14499445
[TBL] [Abstract][Full Text] [Related]
20. American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats.
Mehendale S; Aung H; Wang A; Yin JJ; Wang CZ; Xie JT; Yuan CS
Cancer Chemother Pharmacol; 2005 Jul; 56(1):63-9. PubMed ID: 15791456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
